These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Does MAP2 have a role in predicting the development of anti-NMDAR encephalitis associated with benign ovarian teratoma? A report of six new pediatric cases. Cundiff CA; Elawabdeh N; Naguib MM; Jactel SN; Demellawy DE; Abramowsky CR; Durham MM; Youssef L; Wittkamp ML; Shehata BM Pediatr Dev Pathol; 2015; 18(2):122-6. PubMed ID: 25569473 [TBL] [Abstract][Full Text] [Related]
3. Anti-N-Methyl-D-aspartate Receptor Encephalitis: A Severe, Potentially Reversible Autoimmune Encephalitis. Liu CY; Zhu J; Zheng XY; Ma C; Wang X Mediators Inflamm; 2017; 2017():6361479. PubMed ID: 28698711 [TBL] [Abstract][Full Text] [Related]
4. Clinical and pathogenic significance of IgG, IgA, and IgM antibodies against the NMDA receptor. Hara M; Martinez-Hernandez E; Ariño H; Armangué T; Spatola M; Petit-Pedrol M; Saiz A; Rosenfeld MR; Graus F; Dalmau J Neurology; 2018 Apr; 90(16):e1386-e1394. PubMed ID: 29549218 [TBL] [Abstract][Full Text] [Related]
5. Detection of autoantibody against extracellular epitopes of N-methyl-D-aspartate receptor by cell-based assay. Takano S; Takahashi Y; Kishi H; Taguchi Y; Takashima S; Tanaka K; Muraguchi A; Mori H Neurosci Res; 2011 Nov; 71(3):294-302. PubMed ID: 21839784 [TBL] [Abstract][Full Text] [Related]
6. An Infant Born to a Mother With Anti-N-Methyl-d-Aspartate Receptor Encephalitis. Chourasia N; Watkins MW; Lankford JE; Kass JS; Kamdar A Pediatr Neurol; 2018 Feb; 79():65-68. PubMed ID: 29310908 [TBL] [Abstract][Full Text] [Related]
10. Anti-N-methyl-D-aspartate receptor encephalitis: a common cause of encephalitis in the intensive care unit. Chen X; Li JM; Liu F; Wang Q; Zhou D; Lai X Neurol Sci; 2016 Dec; 37(12):1993-1998. PubMed ID: 27620725 [TBL] [Abstract][Full Text] [Related]
11. Persistent intrathecal antibody synthesis 15 years after recovering from anti-N-methyl-D-aspartate receptor encephalitis. Hansen HC; Klingbeil C; Dalmau J; Li W; Weissbrich B; Wandinger KP JAMA Neurol; 2013 Jan; 70(1):117-9. PubMed ID: 23318518 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of CSF findings in antibody-associated limbic and anti-NMDAR-encephalitis. Malter MP; Elger CE; Surges R Seizure; 2013 Mar; 22(2):136-40. PubMed ID: 23318046 [TBL] [Abstract][Full Text] [Related]
16. Distinct intrathecal interleukin-17/interleukin-6 activation in anti-N-methyl-d-aspartate receptor encephalitis. Byun JI; Lee ST; Moon J; Jung KH; Sunwoo JS; Lim JA; Kim TJ; Shin YW; Lee KJ; Jun JS; Lee HS; Lee WJ; Kim YS; Kim S; Jeon D; Park KI; Jung KY; Kim M; Chu K; Lee SK J Neuroimmunol; 2016 Aug; 297():141-7. PubMed ID: 27397087 [TBL] [Abstract][Full Text] [Related]
17. N-methyl-d-aspartate receptor antibody-related pathologies and pre-existent mental state disorders. Massa F; Franciotta D; Gastaldi M; Mancardi GL; Benedetti L Schizophr Res; 2018 Dec; 202():406-407. PubMed ID: 30539773 [No Abstract] [Full Text] [Related]
18. Comparisons between Psychiatric Symptoms of Patients with Anti-NMDAR Encephalitis and New-Onset Psychiatric Patients. Wang J; Zhang B; Zhang M; Chen J; Deng H; Wang Q; Sun X Neuropsychobiology; 2017; 75(2):72-80. PubMed ID: 29065417 [TBL] [Abstract][Full Text] [Related]